Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Bjerregaard Larsen

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Circulation|July 25, 2012
Letter by christensen et Al regarding article, "new oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation"Thomas Decker Christensen, John Michael Hasenkam, Torben Bjerregaard Larsen
Thrombosis and Haemostasis|June 10, 2011
Self-testing and self-management of oral anticoagulation therapy in childrenThomas Decker Christensen, Torben Bjerregaard Larsen, Vibeke E Hjortdal
The Annals of Thoracic Surgery|October 7, 2014
Postoperative atrial fibrillation prophylaxis after lung surgery: systematic review and meta-analysisLars Peter Riber, Torben Bjerregaard Larsen, Thomas Decker Christensen
TH Open : Companion Journal to Thrombosis and Haemostasis|January 12, 2023
Evaluation of Risk Scores as Predictive Tools for Stroke in Patients with Retinal Artery Occlusion: A Danish Nationwide Cohort StudyMarie Ørskov, Henrik Vorum, Torben Bjerregaard Larsen, et al.
Ugeskrift for Laeger|November 13, 2015
[In Process Citation]Thure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Journal of the American College of Cardiology|May 14, 2016
Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing EvidenceThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Pharmacoepidemiology and Drug Safety|May 28, 2016
Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine careAnders Gorst-Rasmussen, Gregory Y H Lip, Torben Bjerregaard Larsen
Chest|September 11, 2015
Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points?Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
JAMA Internal Medicine|September 6, 2017
All Types of Hemorrhagic Stroke Are Not Created Equally-ReplyPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
Chest|June 12, 2016
ResponsePeter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Circulation|July 25, 2012
Letter by christensen et Al regarding article, "new oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation"Thomas Decker Christensen, John Michael Hasenkam, Torben Bjerregaard Larsen
Thrombosis and Haemostasis|June 10, 2011
Self-testing and self-management of oral anticoagulation therapy in childrenThomas Decker Christensen, Torben Bjerregaard Larsen, Vibeke E Hjortdal
The Annals of Thoracic Surgery|October 7, 2014
Postoperative atrial fibrillation prophylaxis after lung surgery: systematic review and meta-analysisLars Peter Riber, Torben Bjerregaard Larsen, Thomas Decker Christensen
TH Open : Companion Journal to Thrombosis and Haemostasis|January 12, 2023
Evaluation of Risk Scores as Predictive Tools for Stroke in Patients with Retinal Artery Occlusion: A Danish Nationwide Cohort StudyMarie Ørskov, Henrik Vorum, Torben Bjerregaard Larsen, et al.
Ugeskrift for Laeger|November 13, 2015
[In Process Citation]Thure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Journal of the American College of Cardiology|May 14, 2016
Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing EvidenceThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Pharmacoepidemiology and Drug Safety|May 28, 2016
Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine careAnders Gorst-Rasmussen, Gregory Y H Lip, Torben Bjerregaard Larsen
Chest|September 11, 2015
Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points?Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
JAMA Internal Medicine|September 6, 2017
All Types of Hemorrhagic Stroke Are Not Created Equally-ReplyPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
Chest|June 12, 2016
ResponsePeter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Y H Lip
Pageof 19